Common use of Replacement Product Clause in Contracts

Replacement Product. As will be more fully set forth in the Clinical Supply Agreement, GenSci will promptly replace any Licensed Molecule, Licensed Product, or placebo that fails to comply with the requirements of Section 6.1.3 (Requirements) at the time of delivery to Yarrow, at GenSci’s cost and expense.

Appears in 2 contracts

Sources: Exclusive License Agreement (VYNE Therapeutics Inc.), Exclusive License Agreement (VYNE Therapeutics Inc.)